Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas-Reference-Cited by-同舟云学术

Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas

Published:2011-12-16 Issue:16 Volume:118 Page:3954-3961
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ferrario Andrea,Pulsoni Alessandro,Olivero Barbara,Rossi Giuseppe,Vitolo Umberto,Tedeschi Alessandra,Merli Francesco,Rigacci Luigi,Stelitano Caterina,Goldaniga Maria,Mannina Donato,Musto Pellegrino,Rossi Francesca,Gamba Enrica,Baldini Luca

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference43 articles.

1. Small lymphocytic lymphoma: a clinicopathologic analysis of 268 cases;Ben-Ezra;Blood.,1989

2. Indolent nonfollicular lymphomas: characteristics, treatment, and outcome;Coiffier;Semin Hematol.,1999

3. Epidemiology, pathology and treatment of non-follicular indolent lymphomas;Landgren;Leuk Lymphoma.,2008

4. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenstrom's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders;Pangalis;Semin Hematol.,1999

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current approach to Waldenström macroglobulinemia;Blood Reviews;2023-11

2. Nodales Marginalzonenymphom;Indolente Lymphome;2023

3. Marginal zone lymphoma: present status and future perspectives;Haematologica;2022-01-01

4. Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the phase III MabCute study;Haematologica;2021-06-17

5. Nodal Marginal Zone Lymphoma;Hematologic Malignancies;2021